Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy. (Q42750577)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321953%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321953%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321953%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Arun V Krishnan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321953%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Susanna B Park

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321953%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Michael L Friedlander

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321953%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Craig R Lewis

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321953%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Matthew C Kiernan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321953%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

9 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321953%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321953%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321953%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321953%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

367-374

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21321953%20AND%20SRC:MED&resulttype=core&format=json

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

22 January 2020

cites work

1 reference

Risks and benefits of taxanes in breast and ovarian cancer

21 January 2018

1 reference

Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline

21 January 2018

1 reference

Promotion of microtubule assembly in vitro by taxol

21 January 2018

1 reference

Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations

21 January 2018

1 reference

Weekly paclitaxel: an effective and well-tolerated treatment in patients with advanced breast cancer

21 January 2018

1 reference

The role of taxanes in the treatment of breast cancer

21 January 2018

1 reference

Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.

21 January 2018

1 reference

Dose and schedule as determinants of outcomes in chemotherapy for breast cancer

21 January 2018

1 reference

Weekly paclitaxel in the adjuvant treatment of breast cancer.

21 January 2018

1 reference

Phase I study of paclitaxel (taxol) and granulocyte colony stimulating factor (G-CSF) in patients with unresectable malignancy

21 January 2018

1 reference

Assessment of neuropathic pain in cancer patients

21 January 2018

1 reference

The Rochester Diabetic Neuropathy Study: Reassessment of tests and criteria for diagnosis and staged severity

21 January 2018

1 reference

Oxaliplatin-induced neurotoxicity and the development of neuropathy

21 January 2018

1 reference

21 January 2018

1 reference

Threshold tracking techniques in the study of human peripheral nerve

21 January 2018

1 reference

Axonal ion channels from bench to bedside: a translational neuroscience perspective

21 January 2018

1 reference

Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing

21 January 2018

1 reference

Decreased electrical excitability of peripheral nerves in demyelinating polyneuropathies

21 January 2018

1 reference

Peripheral neurotoxicity of weekly paclitaxel chemotherapy: a schedule or a dose issue?

21 January 2018

1 reference

Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy.

21 January 2018

1 reference

Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy

21 January 2018

1 reference

Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity.

21 January 2018

1 reference

Oxaliplatin and axonal Na+ channel function in vivo

21 January 2018

1 reference

The pathophysiology of oxaliplatin-induced neurotoxicity

21 January 2018

1 reference

Assessment of nerve excitability in toxic and metabolic neuropathies

21 January 2018

1 reference

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies

21 January 2018

1 reference

Early predictors of peripheral neurotoxicity in cisplatin and paclitaxel combination chemotherapy.

21 January 2018

1 reference

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study

21 January 2018

1 reference

Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks

21 January 2018

1 reference

Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine

21 January 2018

1 reference

Excitability of human axons

21 January 2018

1 reference

Progression of paclitaxel-induced neuropathy following discontinuation of treatment

21 January 2018

1 reference

General and recent aspects of the chemistry and structure-activity relationships of taxoids

21 January 2018

1 reference

Taxol impairs anterograde axonal transport of microinjected horseradish peroxidase in dorsal root ganglia neurons in vitro

21 January 2018

1 reference

Microtubule assembly, organization and dynamics in axons and dendrites

21 January 2018

1 reference

Vincristine neuropathy: an electrophysiological and histological study

21 January 2018

1 reference

Nucleolar damage correlates with neurotoxicity induced by different platinum drugs

21 January 2018

1 reference

The pattern and diagnostic criteria of sensory neuronopathy: a case-control study

21 January 2018

1 reference

Early phase of vincristine neuropathy in man. Electrophysiological evidence for a dying-back phenomenon, with transitory enhancement of spinal transmission of the monosynaptic reflex

21 January 2018

1 reference

Vincristine neuropathy. Clinical and electrophysiological observations

21 January 2018

1 reference

Calpain inhibition protects against Taxol-induced sensory neuropathy

21 January 2018

1 reference

Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction.

21 January 2018

1 reference

Paclitaxel induces axonal microtubules polar reconfiguration and impaired organelle transport: implications for the pathogenesis of paclitaxel-induced polyneuropathy

21 January 2018

1 reference

Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer an

21 January 2018

1 reference